Medical Lasers and Medical Fibers .: biolitec .: Market Leading Biomedical technology

In The News

Press Kit

Seminars

Trade Shows

biolitec is making news!

We invite you to check back frequently for updated press coverage. For additional information, please visit About biolitec. To receive news and announcements by email sign-up for our e-Newsletter.

biolitec AG - study confirms very good results for cancer drug Foscan ®
4/23/2007
Jena, April 23, 2007 – biolitec AG, Jena could successfully complete its confirmatory study for Foscan® which was required to maintain Foscan’s® EMEA (European Medicines Agency) approval.
Read More

Approval study on ELVeS™ started in Japan
4/12/2007
Jena, April 12th, 2006 – biolitec AG explores new potential in Japan after the successful market launches in Europe and the United States.
Read More

biolitec AG commences contract negotiations with US biotech companies on out-licensing and clinical development of its cancer drug Foscan®
2/1/2007
Jena, February 1st, 2007 - biolitec AG, listed in the Prime Standard of the Frankfurt stock exchange will commence contract negotiations with two US biotech companies next week.
Read More

biolitec’s annual general meeting decides on share repurchase
12/14/2006
Jena, December 14th, 2006 – biolitec’s annual general meeting has decided on the possibility of repurchasing over one million shares.
Read More

biolitec AG received subsidies for high power laser development
10/28/2005
Jena, October 18, 2005 – CeramOptec GmbH a 100% subsidiary of biolitec AG in cooperation with leading research institutes and partners in the industry received the confirmation for subsidies from the German Federal Ministry of Education and Research (BMBF) about aid money for a cooperation project with a complete project volume of Euro 3,9 millions.
Read More

biolitec AG achieved revenues of Euro 5.65 millions in the first quarter
3/11/2005
Jena, November 30, 2005 – biolitec AG listed in the Prime Standard of the Frankfurt stock exchange (ISIN DE0005213409) managed to display during the first quarter of the actual fiscal year 2005/2006 a slight positive trend. Consolidated turnover amounted to Euro 5.65 millions (last fiscal year Euro 5.55 millions).
Read More

New ELVeS Marketing and Procedure Kits
10/31/2003

Read More

Fall Seminar Schedule: ELVeS Vein Treatment
9/29/2003

Read More

810 vs. 980 nm Dental Lasers - Conductive vs. Radiant Energy
2/27/2003

Read More

Megabeam Laser Fibers for Endovenous Procedures
2/27/2003

Read More

First

Last

Records 11 to 20 of 22


lasers/fibers biolitec cutting edge medical lasers systems and fibers can benefit your patients and practice. Learn how


In-Office BPH Treatment Vein Treatment More doctors are choosing EVOLVE SLV™ and ELVeS™ to provide these in-office treatments. We can help you locate a doctor near you.


resources SUBSCRIBE TO E-NEWSLETTER SEMINARS biolitec provides free laser education by specialty for all of our laser owners and others. Learn More NEWS As a leading developer in the field of medical laser treatment and technology biolitec is always on the cutting edge. Read now


Request a Quote Save more of your income by spending less on your disposables. Enjoy low prices you can only get directly from the manufacturer. Learn how